You will be responsible for the overall technology strategy, IT architecture, product development, system integration and building a technical department in DoMore Diagnostics.
The CTO will play a central role in shaping the future of DoMore Diagnostics together with the board, the CEO, and the rest of the management team. We are now establishing the core team at DoMore Diagnostics, and we are looking for you who are keen on setting the direction, executing the technology strategy, and expanding our tech team. The key researchers behind the algorithms at Institute for Cancer Genetics and Informatics at Oslo University Hospital and Oxford University in the UK are shareholders in DoMore Diagnostics and are very supportive of our company. Today our team consist of 2 people, as well as the Board and our investors. Colorectal cancer is our furthest developed algorithm and has been published in The Lancet, one of the most prestigious medical journals in the world. The DoMore! Algorithm is built to predict poor vs. We were established to meet the need for novel methods in precision medicine to ensure the right treatment for each cancer patient and avoid overtreatment and undertreatment. Based on 5 years of top international research, backed by top Norwegian tech investors we are ready to commercialize AI algorithms for detecting and providing a prognosis for patients with cancer. Advanced AI technology is set for a breakthrough in medicine, and several megatrends are pushing for AI solutions in cancer diagnostics.
0 kommentar(er)
